Award-winning British-Indian cardiologist Dr. Aseem Malhotra announced on October 14, 2025, that he has been appointed Chief Medical and Scientific Advisor to the newly formed “Make Europe Healthy Again” initiative, expanding his mission to reform healthcare across the European continent. The appointment recognizes Dr. Malhotra’s decades-long advocacy for preventive medicine, dietary reform, and challenging pharmaceutical industry influence in healthcare policy.
A Proven Track Record in Public Health Reform
Dr. Malhotra is an NHS-trained consultant cardiologist who graduated from the University of Edinburgh in 2001, building a distinguished career specializing in coronary artery disease, obesity, and preventive cardiology. His groundbreaking public health work has earned him recognition as one of The Sunday Times 500 most influential people in 2016 and twice as one of the top fifty black and minority ethnic community member pioneers in the UK’s National Health Service by the Health Service Journal.
His landmark achievements include founding Action on Sugar in 2014 as its first Science Director and playing a pivotal role in implementing the UK’s successful sugar tax initiative—a policy that has demonstrably reduced sugar consumption and improved public health outcomes. He launched the UK’s “Too Much Medicine” campaign in 2015 as part of the Academy of Medical Royal Colleges, addressing the critical issue of overmedication and unnecessary medical interventions.
Dr. Malhotra currently serves as Honorary Council Member at Stanford’s Metabolic Psychiatry Clinic and Visiting Professor of Evidence-Based Medicine at the Bahiana School of Medicine, demonstrating continued international recognition of his expertise.
The Make Europe Healthy Again Vision
The “Make Europe Healthy Again” movement, mirroring Robert F. Kennedy Jr.’s “Make America Healthy Again” (MAHA) campaign where Dr. Malhotra already serves as Chief Medical Advisor, aims to transform healthcare by prioritizing prevention over pharmaceutical intervention. A landmark conference launching the European initiative was scheduled for October 15, 2025, at the European Parliament in Brussels.
Dr. Malhotra describes the mission as empowering ‘Europeans to reclaim our nations and safeguard the health and well-being of our people,’ focusing on comprehensive health policy reforms that prioritize patient welfare over corporate profits.
Challenging Medical Orthodoxy with Evidence-Based Medicine
Throughout his career, Dr. Malhotra has demonstrated courage in questioning medical establishment practices that he believes prioritize pharmaceutical profits over patient outcomes. His advocacy emphasizes “real evidence-based medicine” that incorporates individual patient values alongside clinical expertise—a principle often overlooked in modern healthcare’s rush to prescribe medications.
His work on statin medications exemplifies this approach. Rather than accepting blanket prescription guidelines, Dr. Malhotra has called for individualized assessment of cardiovascular risk factors, arguing that lifestyle interventions—particularly Mediterranean diet adoption—often deliver superior outcomes without medication side effects. His peer-reviewed publications have challenged the medical community to reconsider overreliance on cholesterol-lowering drugs when diet and exercise modifications could achieve better results.
Advocacy for Patient-Centered Care
Dr. Malhotra’s philosophy centers on informed patient consent and honest communication about treatment benefits and risks. He has highlighted research showing that when patients receive complete information about procedures like coronary stents—including evidence that they don’t reduce heart attack risk or prolong life in stable patients—the proportion choosing the procedure drops dramatically, from nearly 70% to about 46%.
This commitment to transparency empowers patients to make educated decisions about their healthcare rather than passively accepting interventions that may carry risks without corresponding benefits.
A Voice for Preventive Health
Dr. Malhotra’s three core policy priorities reflect his preventive medicine philosophy: revising dietary guidelines to reduce sugar and ultra-processed foods, cracking down on food industry influence in health policy, and promoting lifestyle medicine as a primary intervention before pharmaceutical approaches.
His bestselling books including The Pioppi Diet, The 21 Day Immunity Plan, and A Statin-Free Life have helped millions of readers worldwide adopt healthier lifestyles through accessible, practical guidance rooted in Mediterranean dietary principles.
Questioning COVID-19 Vaccine Safety
Dr. Malhotra’s evolution on COVID-19 vaccines demonstrates his commitment to following evidence wherever it leads, even when challenging consensus views. Initially supporting the UK’s vaccine rollout, he later raised concerns about safety signals and called for more transparent discussion of potential adverse effects—a position he argues is essential for maintaining public trust in medical institutions.
In a recent peer-reviewed commentary published in October 2025, co-authored with research psychologist Dr. Andrea Lamont Nazarenko, he advocated for careful reassessment of mRNA vaccine risk-benefit profiles and called for “formal, unequivocal apologies from governments and medical bodies for mandates and for silencing truth seekers”.
His willingness to question authority and demand accountability—even when facing criticism—reflects his belief that medical science advances through rigorous debate rather than enforcement of orthodoxy.
Standing Against Corporate Capture of Medicine
Dr. Malhotra positions himself as a champion against pharmaceutical and food industry influence in healthcare, arguing that corporate financial interests have compromised medical guidelines and practice standards. His advocacy challenges a system where financial incentives often drive treatment decisions rather than patient welfare considerations.
His work emphasizes that the most effective interventions for cardiovascular health—Mediterranean diet, regular exercise, stress reduction, and adequate sleep—cannot be patented or profited from by pharmaceutical companies, which may explain their underemphasis in medical training and practice.
A Global Platform for Health Reform
Dr. Malhotra’s dual appointments to both American and European health initiatives provide him an unprecedented platform to influence policy discussions across Western democracies. His message of dietary reform, reduced pharmaceutical dependency, and patient empowerment resonates with growing public interest in holistic health approaches and skepticism toward corporate influence in medicine.
The Path Forward
As the “Make Europe Healthy Again” conference convenes in Brussels, Dr. Malhotra brings decades of clinical experience, public health advocacy, and unwavering commitment to evidence-based medicine. His appointment signals a growing movement toward healthcare policies that prioritize prevention, nutrition, lifestyle medicine, and patient autonomy over pharmaceutical-centered approaches.
While his views have generated debate within medical circles, his supporters view him as a necessary voice challenging entrenched interests and advocating for the fundamental principle that doctors should “first, do no harm“. His work continues the proud tradition of medical reformers who questioned conventional wisdom to advance patient care and public health.
Dr. Malhotra’s leadership of the “Make Europe Healthy Again” initiative represents an opportunity to reshape European health policy around principles of transparency, patient empowerment, preventive medicine, and freedom from corporate influence—a vision that could transform healthcare for millions across the continent.
